Examination of packaging and labeling materials for suitability and correctness before packaging operations is not performed.
Inspection Record
Genzyme Corporation — FDA 483 Findings
Inspectors Lizaida Perez · Priscilla M PastranaThe inspectors who signed the published document.Inspector lookup
View the regulator's official source The source document is always the basis for judgement.
Findings
Written records are not always made of investigations into unexplained discrepancies.
Procedures designed to assure that correct labeling are used for drug products are not followed.
Similar findings at other companies
GRM selected findings from the same type of public document whose wording is close to a finding in this document. One per company.
- TAILSTORM HEALTH INC2026-08-28 · US FDASimilar to finding 2 Written records are not always made of investigations into unexplained discrepancies.
- Bello Bio LLC2025-12-16 · US FDASimilar to finding 3 Procedures designed to assure that correct labels and labeling are used for drug products are not written.
A record as of the US FDA document published on 2026-10-27. Check the agency's announcements for any later corrective action, and rely on the original text. Translation and classification are machine-made.